Foundry Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Foundry Partners’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-131,885	Closed	-$6.07M	–	450
2016 Q3	$6.07M	Sell	131,885 -74,707	-36%	-$3.9M	0.32%	113
2016 Q2	$10.4M	Sell	206,592 -22,265	-10%	-$1.19M	0.59%	42
2016 Q1	$12.2M	Buy	228,857 +14,715	+7%	+$863K	1.21%	19
2015 Q4	$14.1M	Sell	214,142 -3,045	-1%	-$188K	1.17%	20
2015 Q3	$12.3M	Sell	217,187 -64,730	-23%	-$4.2M	1.07%	22
2015 Q2	$16.7M	Buy	281,917 +18,916	+7%	+$1.17M	1.33%	11
2015 Q1	$16.4M	Buy	263,001 +47,211	+22%	+$2.74M	1.36%	10
2014 Q4	$12.4M	Buy	215,790 +76,121	+55%	+$4.24M	1.02%	29
2014 Q3	$7.51M	Buy	139,669 +25,215	+22%	+$1.34M	0.7%	57
2014 Q2	$6M	Sell	114,454 -4,208	-4%	-$215K	0.56%	83
2014 Q1	$6.27M	Sell	118,662 -5,456	-4%	-$252K	0.59%	74
2013 Q4	$4.97M	Buy	+124,118	New	+$4.89M	0.45%	87

Other funds holding TEVA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return